Results 171 to 180 of about 33,325 (191)
Reprogramming the immunosuppressive microenvironment in glioblastoma: the microglia-MDSC-Treg axis and translational therapeutic strategies. [PDF]
Front OncolAydın HA, Keskin E, Kalaycı M.
europepmc +1 more source
CD39 and control of cellular immune responses [PDF]
Purinergic Signalling, 2007 CD39 is the cell surface-located prototypic member of the ecto-nucleoside triphosphate diphosphohydrolase (E-NTPDase) family. Biological actions of CD39 are a consequence (at least in part) of the regulated phosphohydrolytic activity on extracellular ...
Simon C Robson +2 more
exaly +3 more sources
The ectonucleotidase cd39/ENTPDase1 modulates purinergic‐mediated microglial migration
Glia, 2008 Microglia is activated by brain injury. They migrate in response to ATP and although adenosine alone has no effect on wild type microglial migration, we show that inhibition of adenosine receptors impedes ATP triggered migration.
Simon C Robson, Helmut Kettenmann
exaly +2 more sources
CD39 transforming cancer therapy by modulating tumor microenvironment [PDF]
Cancer LettersCD39 is a pivotal enzyme in cancer, regulating immune response and tumor progression via extracellular ATP and adenosine in the tumor microenvironment (TME).
Wenxue Ma, Qingqing Wang
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
A2AR limits IL-15-induced generation of CD39+ NK cells with high cytotoxicity
International Immunopharmacology, 2023Lu Zong, Longxiang Tao, Jingjing Cong
exaly
CD39 pathway inhibits Th1 cell function in tuberculosis
Immunology, 2022Ziyong Sun, Ziyong Sun, Feng Wang
exaly
Implications of CD39 in immune-related diseases
International Immunopharmacology, 2020Chunxia Li
exaly